En hypotese om forbindelsen mellem visceral lipomatose og proteasehæmmere samt lipoatrofi og nukleosid- revers transkriptase- hæmmere er blevet opstillet.
A connection between visceral 5 lipomatosis and protease inhibitors and lipoatrophy and nucleoside reverse transcriptase inhibitors has been hypothesised.